Todralazine

This classification denotes a vasodilating agent with the molecular formula C11H12N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WEN3K83YKD, chemically known as hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester (9ci) but generally known as todralazine, which bears US NIH Compound Identifier 5501. European Medicines Agency schedules Todralazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11141MIG. The term TODRALAZINE is an International Non-Proprietary Name. TODRALAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule todralazine under HS 29339990 and SITC 51577. As of Q4 2014, TODRALAZINE remains the US FDA Preferred Term for this commodity. Todralazine bears US NLM identifiers UMLS ID C0040354 and NCI Concept Code C77080. SMILES: CCOC(=O)NNC1=NN=CC2=CC=CC=C21.